P&G closes diagnostics deal
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble and Inverness Medical Innovations complete a previously announced deal to create SPD Swiss Precision Diagnostics, a 50/50 joint venture business that develops, manufactures and markets diagnostic products, the firms announce May 17. The new company is headquartered in Geneva and will be the world's leading provider of home pregnancy test and fertility/ovulation monitoring products with brands including Clearblue and Fact Plus, say the firms, which outlined plans for the partnership in January (1"The Tan Sheet" Jan. 1, 2007, p. 10)...
You may also be interested in...
P&G Moves Into Consumer Diagnostics With Inverness Joint Venture
Procter & Gamble enters the consumer diagnostic products business with an agreement to form a 50/50 joint venture with Waltham, Mass.-based Inverness Medical Innovations
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.